Novel pharmaceutical combinations for the treatment of respiratory disorders

Details for Australian Patent Application No. 2006301329 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Pieper, Michael P.; Bouyssou, Thierry; Schnapp, Andreas

Agent Davies Collison Cave

Pub. Number AU-B-2006301329

PCT Pub. Number WO2007/042467

Priority 05109374.8 10.10.05 EP

Filing date 6 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 2 August 2012

International Classifications

A61K 31/538

A61K 31/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/46 - 8-Azabicyclo [3.2.1] octane

A61P 9/06 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 11/06 Drugs for disorders of the respiratory system

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/042467 Priority application(s): WO2007/042467

2 August 2012 Application Accepted

  Published as AU-B-2006301329

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301330-Aerosol formulation for the inhalation of beta agonists

2006301311-Aqueous binder composition